InvestorsHub Logo
Followers 42
Posts 1040
Boards Moderated 0
Alias Born 04/02/2017

Re: ~MulaGreen~ post# 3965

Wednesday, 08/23/2017 9:57:56 AM

Wednesday, August 23, 2017 9:57:56 AM

Post# of 5873
And then some!!!

ImmunoCellular Therapeutics, Ltd. (NYSE:IMUC) has accumulated 75.71% over the course of one week. It seems that ImmunoCellular Therapeutics, Ltd. (NYSE:IMUC) might see weakness given an ABR of 4 or Sell rating. Analysts, on average, seem bullish as they suggest IMUC is worth $4.63 more, giving a target price of $5 a share.

Source:
https://allstocknews.com/2017/08/23/critical-levels-to-breach-walter-investment-management-corp-wac-immunocellular-therapeutics-ltd-imuc/